{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:53Z","timestamp":1792782473701,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)","id":[{"id":"https:\/\/ror.org\/01zgy1s35","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Schwere psychische Erkrankungen (\u201esevere mental illness\u201c, SMI) sind mit chronischen Verl\u00e4ufen, erheblichen funktionellen Einschr\u00e4nkungen und erh\u00f6hter Mortalit\u00e4t assoziiert. Gleichzeitig ist ihre Versorgung durch Fragmentierung, mangelnde Kontinuit\u00e4t und unzureichende Koordination gekennzeichnet. Vor diesem Hintergrund gewinnt Patientensteuerung als Ansatz zur Verbesserung von Versorgungsqualit\u00e4t und Effizienz an Bedeutung. Ziel dieser narrativen \u00dcbersichtsarbeit ist es, zentrale evidenzbasierte Versorgungsmodelle f\u00fcr Menschen mit SMI darzustellen, strukturelle Herausforderungen der Versorgung zu analysieren und daraus Prinzipien einer effektiven Patientensteuerung abzuleiten.<\/jats:p>\n                  <jats:p>Die Evidenz zeigt, dass insbesondere kontinuierliche und multiprofessionelle Versorgungsans\u00e4tze \u2013\u00a0wie Assertive Community Treatment (ACT; intensive gemeindenahe Behandlung), Crisis Resolution Teams (CRT; ambulante Krisenintervention durch multiprofessionelle Teams) und Fr\u00fchinterventionsprogramme\u00a0\u2013 klinische und funktionelle Outcomes verbessern, station\u00e4re Behandlungen reduzieren und Kontinuit\u00e4t herstellen k\u00f6nnen. Gleichzeitig wird deutlich, dass die isolierte Implementierung einzelner Interventionsmodelle nicht ausreicht, um strukturelle Defizite nachhaltig zu adressieren.<\/jats:p>\n                  <jats:p>Integrierte und gestufte Versorgungsmodelle erm\u00f6glichen die systematische Verkn\u00fcpfung evidenzbasierter Interventionen entlang eines kontinuierlichen Versorgungspfades. Aktuelle Befunde zeigen, dass solche Ans\u00e4tze die Versorgungsqualit\u00e4t verbessern und gleichzeitig ohne Mehrkosten implementiert werden k\u00f6nnen und sogar Einsparpotenziale erschlie\u00dfen. Patientensteuerung stellt damit einen zentralen Ansatz dar, um Versorgungskontinuit\u00e4t zu st\u00e4rken, Versorgungsbr\u00fcche zu reduzieren und Patientenergebnisse sowie Ressourceneffizienz nachhaltig zu verbessern.<\/jats:p>","DOI":"10.1007\/s00103-026-04299-3","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:51:32Z","timestamp":1789548692000},"page":"1213-1220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patientensteuerung bei schweren psychischen Erkrankungen\u00a0\u2013 Herausforderungen, Modelle und Perspektiven","Patient navigation in severe mental illness\u2014challenges, models, and perspectives"],"prefix":"10.1007","volume":"69","author":[{"given":"Martin","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Gallinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"4299_CR1","unstructured":"G\u00fchne U, Weinmann S, Becker T, Riedel-Heller SG (2025) S3-Leitlinie Psychosoziale Therapien bei schweren psychischen Erkrankungen. AWMF-Registernr. 038-020. Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Berlin."},{"key":"4299_CR2","doi-asserted-by":"crossref","unstructured":"Lambert M, Kraft V, Rohenkohl A et\u00a0al. (2019) Innovative Versorgungsmodelle f\u00fcr Menschen mit schizophrenen Erkrankungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz\u00a062:163\u2013172","DOI":"10.1007\/s00103-018-2868-y"},{"key":"4299_CR3","doi-asserted-by":"crossref","unstructured":"Lawrence EG, Zahid U, Thomson AC et\u00a0al. (2025) Psychosocial and demographic factors associated with physical multimorbidity in severe mental illness: a\u00a0systematic review. Schizophr Bull online first","DOI":"10.1093\/schbul\/sbaf128"},{"key":"4299_CR4","doi-asserted-by":"crossref","unstructured":"Walker ER, McGee RE, Druss BG (2015) Mortality in mental disorders and global disease burden implications. JAMA Psychiatry\u00a072:334\u2013341","DOI":"10.1001\/jamapsychiatry.2014.2502"},{"key":"4299_CR5","doi-asserted-by":"crossref","unstructured":"Chesney E, Goodwin GM, Fazel S (2014) Risks of all-cause and suicide mortality in mental disorders: a\u00a0meta-review. World Psychiatry\u00a013:153\u2013160","DOI":"10.1002\/wps.20128"},{"key":"4299_CR6","doi-asserted-by":"crossref","unstructured":"De Hert M, Correll CU, Bobes J et\u00a0al. (2011) Physical illness in patients with severe mental disorders: prevalence and impact. World Psychiatry\u00a010:52\u201377","DOI":"10.1002\/j.2051-5545.2011.tb00014.x"},{"key":"4299_CR7","unstructured":"OECD (2021) A new benchmark for mental health systems: tackling the social and economic costs of mental ill-health. OECD Publishing, Paris"},{"key":"4299_CR8","doi-asserted-by":"crossref","unstructured":"Dixon LB, Holoshitz Y, Nossel I (2016) Treatment engagement of individuals experiencing mental illness: review and update. World Psychiatry\u00a015:13\u201320","DOI":"10.1002\/wps.20306"},{"key":"4299_CR9","doi-asserted-by":"crossref","unstructured":"Thornicroft G (2011) Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry 199:441\u2013442","DOI":"10.1192\/bjp.bp.111.092718"},{"key":"4299_CR10","doi-asserted-by":"crossref","unstructured":"Teggart K, Lockhart E, Wright N et\u00a0al. (2023) Effectiveness of system navigation programs linking primary care with community-based services. BMC Health Serv Res\u00a023:450","DOI":"10.1186\/s12913-023-09424-5"},{"key":"4299_CR11","doi-asserted-by":"crossref","unstructured":"Waid J, Halpin M (2021) Mental health service navigation: a\u00a0scoping review. Soc Work Ment Health\u00a019:1\u201322","DOI":"10.1080\/15332985.2020.1870646"},{"key":"4299_CR12","unstructured":"McDonald KM, Sundaram V, Bravata DM et\u00a0al. (2007) Care coordination. Agency for Healthcare Research and Quality, Rockville"},{"key":"4299_CR13","doi-asserted-by":"crossref","unstructured":"Correll CU, Galling B, Pawar A et\u00a0al. (2018) Comparison of early intervention services vs treatment as usual for early-phase psychosis: a\u00a0systematic review and meta-analysis. JAMA Psychiatry\u00a075:555\u2013565","DOI":"10.1001\/jamapsychiatry.2018.0623"},{"key":"4299_CR14","doi-asserted-by":"crossref","unstructured":"Marshall M, Lockwood A (2011) Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev CD001089","DOI":"10.1002\/14651858.CD001089.pub2"},{"key":"4299_CR15","doi-asserted-by":"crossref","unstructured":"Bond GR, Drake RE (2015) The critical ingredients of assertive community treatment. World Psychiatry\u00a014:240\u2013242","DOI":"10.1002\/wps.20234"},{"key":"4299_CR16","doi-asserted-by":"crossref","unstructured":"Lambert M, Koenig HH, Karow A et\u00a0al. (2024) Stepped, evidence-based and integrated care service model vs usual care for mental disorders: a\u00a0randomized controlled trial. Psychiatry Res 339:116007","DOI":"10.1016\/j.psychres.2024.116007"},{"key":"4299_CR17","doi-asserted-by":"crossref","unstructured":"Zimmermann A, Kreis L, Jan\u00dfen C et\u00a0al. (2026a) Costs and cost-effectiveness of stepped integrated care. Psychiatry Res 360:117021","DOI":"10.1016\/j.psychres.2026.117021"},{"key":"4299_CR18","doi-asserted-by":"crossref","unstructured":"Burns T, Catty J, Dash M et\u00a0al. (2007) Use of intensive case management to reduce time in hospital in people with severe mental illness: systematic review and meta-regression. BMJ 335:336","DOI":"10.1136\/bmj.39251.599259.55"},{"key":"4299_CR19","doi-asserted-by":"crossref","unstructured":"Dieterich M, Irving CB, Bergman H et\u00a0al. (2017) Intensive case management for severe mental illness. Cochrane Database Syst Rev\u00a01:CD007906","DOI":"10.1002\/14651858.CD007906.pub3"},{"key":"4299_CR20","doi-asserted-by":"publisher","unstructured":"Paton F, Wright K, Ayre N, et\u00a0al. (2016) Improving outcomes for people in mental health crisis: a\u00a0rapid synthesis of the evidence for available models of care. Health Technol. Assess.\u00a020, 1\u2013162 https:\/\/doi.org\/10.3310\/hta20030","DOI":"10.3310\/hta20030"},{"key":"4299_CR21","doi-asserted-by":"crossref","unstructured":"Murphy S, Irving CB, Adams CE et\u00a0al. (2012) Crisis intervention for people with severe mental illnesses. Cochrane Database Syst Rev\u00a05:CD001087","DOI":"10.1002\/14651858.CD001087.pub4"},{"key":"4299_CR22","doi-asserted-by":"crossref","unstructured":"Ponka D, Agbata E, Kendall C et\u00a0al. (2020) The effectiveness of case management interventions for the homeless and vulnerably housed. PLoS One\u00a015:e0230896","DOI":"10.1371\/journal.pone.0230896"},{"key":"4299_CR23","doi-asserted-by":"crossref","unstructured":"Kakuma R, Minas H, van Ginneken N et\u00a0al. (2017) Human resources for mental health care: current situation and strategies for action. Lancet 378:1654\u20131663","DOI":"10.1016\/S0140-6736(11)61093-3"},{"key":"4299_CR24","doi-asserted-by":"crossref","unstructured":"Ruggeri M, Leese M, Thornicroft G et\u00a0al. (2000) Definition and prevalence of severe mental illness. Br J Psychiatry 177:149\u2013155","DOI":"10.1192\/bjp.177.2.149"},{"key":"4299_CR25","doi-asserted-by":"crossref","unstructured":"Parabiaghi A, Bonetto C, Ruggeri M et\u00a0al. (2006) Severe and persistent mental illness: a\u00a0methodological review. Soc Psychiatry Psychiatr Epidemiol\u00a041:457\u2013463","DOI":"10.1007\/s00127-006-0048-0"},{"key":"4299_CR26","unstructured":"Delespaul, P.H., de consensusgroep, E.P.A. (2013) Consensus regarding the definition of persons with severe mental illness and the number of such persons in the Netherlands. Tijdschr Psychiatr\u00a055, 427\u2013438"},{"key":"4299_CR27","unstructured":"Bagalman E, Napili A (2015) Serious mental illness: definitions and epidemiology. Congressional Research Service Report R43047, Washington, DC"},{"key":"4299_CR28","unstructured":"Substance Abuse and Mental Health Services Administration (2022) Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (NSDUH). SAMHSA, Rockville, MD"},{"key":"4299_CR29","unstructured":"World Health Organization (2008) Policies and practices for mental health in Europe: Meeting the challenges. WHO Regional Office for Europe, Copenhagen"},{"key":"4299_CR30","unstructured":"World Health Organization (2022) World mental health report: transforming mental health for all. World Health Organization, Geneva. https:\/\/www.who.int\/publications\/i\/item\/9789240049338. Zugegriffen: 24.\u00a0Juni 2026"},{"key":"4299_CR31","unstructured":"Gemeinsamer Bundesausschuss (2021) Richtlinie \u00fcber die berufsgruppen\u00fcbergreifende, koordinierte und strukturierte Versorgung insbesondere f\u00fcr schwer psychisch kranke Versicherte mit komplexem psychiatrischen oder psychotherapeutischen Behandlungsbedarf (KSVPsych-RL). Bundesanzeiger AT 18.02.2021 B5"},{"key":"4299_CR32","doi-asserted-by":"crossref","unstructured":"Zimmermann a, Gerke L, Jan\u00dfen C, et\u00a0al. (2026b). Definition, Erkennung und Behandlung der therapieresistenten Depression. Psychopharmakotherapie\u00a033: 16\u201325","DOI":"10.52778\/ppt20260002"},{"key":"4299_CR33","doi-asserted-by":"crossref","unstructured":"Fazel S, Geddes JR, Kushel M (2014) The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations. Lancet 384:1529\u20131540","DOI":"10.1016\/S0140-6736(14)61132-6"},{"key":"4299_CR34","doi-asserted-by":"crossref","unstructured":"Fazel S, Khosla V, Doll H, Geddes J (2008) The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis. PLoS Med\u00a05:e225","DOI":"10.1371\/journal.pmed.0050225"},{"key":"4299_CR35","doi-asserted-by":"crossref","unstructured":"Aubry T, Goering P, Veldhuizen S et\u00a0al. (2016) A multiple-city randomized controlled trial of Housing First with assertive community treatment for homeless people with severe mental illness. Psychiatr Serv\u00a067:275\u2013281","DOI":"10.1176\/appi.ps.201400587"},{"key":"4299_CR36","doi-asserted-by":"crossref","unstructured":"Schreiter S, Bermpohl F, Krausz M et\u00a0al. (2017) The prevalence of mental illness in homeless people in Germany. Dtsch \u00c4rztebl Int 114:665\u2013672","DOI":"10.3238\/arztebl.2017.0665"},{"key":"4299_CR37","doi-asserted-by":"crossref","unstructured":"Ayano G, Shumet S, Tesfaw G, Tsegay L (2019) The prevalence of schizophrenia and other psychotic disorders among homeless people: a\u00a0systematic review and meta-analysis. BMC Psychiatry\u00a019:370","DOI":"10.1186\/s12888-019-2361-7"},{"key":"4299_CR38","doi-asserted-by":"crossref","unstructured":"Vigo D, Thornicroft G, Atun R (2016) Estimating the true global burden of mental illness. Lancet Psychiatry\u00a03:171\u2013178","DOI":"10.1016\/S2215-0366(15)00505-2"},{"key":"4299_CR39","doi-asserted-by":"crossref","unstructured":"Aldridge RW, Story A, Hwang SW et\u00a0al. (2018) Morbidity and mortality in homeless individuals in high-income countries: a\u00a0systematic review and meta-analysis. Lancet 391:241\u2013250","DOI":"10.1016\/S0140-6736(17)31869-X"},{"key":"4299_CR40","doi-asserted-by":"crossref","unstructured":"K\u00f6nig HH, K\u00f6nig H, Gallinat J et\u00a0al. (2023) Excess costs of mental disorders by level of severity. Soc Psychiatry Psychiatr Epidemiol\u00a058:973\u2013988","DOI":"10.1007\/s00127-022-02298-8"},{"key":"4299_CR41","doi-asserted-by":"crossref","unstructured":"Rohenkohl AC, Daubmann A, Gallinat J et\u00a0al. (2022) Health-related quality of life in severe psychotic disorders during integrated care. Health Qual Life Outcomes\u00a020:133","DOI":"10.1186\/s12955-022-02039-0"},{"key":"4299_CR42","doi-asserted-by":"crossref","unstructured":"Nielsen RE, Banner J, Jensen SE (2021) Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol\u00a018:136\u2013145","DOI":"10.1038\/s41569-020-00463-7"},{"key":"4299_CR43","doi-asserted-by":"crossref","unstructured":"Vigod SN, Kurdyak PA, Dennis CL et\u00a0al. (2013) Transitional interventions to reduce early psychiatric readmissions. Br J Psychiatry 202:187\u2013194","DOI":"10.1192\/bjp.bp.112.115030"},{"key":"4299_CR44","doi-asserted-by":"crossref","unstructured":"Park AL, Jez O, Kilian R et\u00a0al. (2025) A comparison of the costs and patterns of expenditure for care for severe mental illness in five countries. Epidemiol Psychiatr Sci\u00a034:e40","DOI":"10.1017\/S2045796025100140"},{"key":"4299_CR45","doi-asserted-by":"crossref","unstructured":"Vega-Mart\u00ednez S, Pab\u00f3n-Carrasco M, Unanue-Arza S (2026) Assertive community treatment and ACT-derived outreach models: a\u00a0scoping review of adaptations, fidelity and outcomes. Community Ment Health J","DOI":"10.1007\/s10597-026-01607-8"},{"key":"4299_CR46","unstructured":"Lambert M, Bock T, Sch\u00f6ttle D et\u00a0al. (2010) Assertive community treatment as part of integrated care versus standard care: a\u00a012-month trial. Schizophr Res 123:93\u2013100"},{"key":"4299_CR47","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ttle D, Karow A, Schimmelmann BG et\u00a0al. (2014) Effectiveness of integrated care including therapeutic assertive community treatment. J\u00a0Clin Psychiatry\u00a075:1371\u20131379","DOI":"10.4088\/JCP.13m08817"},{"key":"4299_CR48","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ttle D, Ruppelt F, Schimmelmann BG, et\u00a0al. (2019) Reduction of involuntary admissions in patients with severe psychotic disorders treated in the ACCESS integrated care model including therapeutic assertive community treatment. Front Psychiatry\u00a010:736","DOI":"10.3389\/fpsyt.2019.00736"},{"key":"4299_CR49","doi-asserted-by":"crossref","unstructured":"Ruppelt F, Rohenkohl A, Kraft V, et\u00a0al. (2020) Course, remission and recovery in patients with severe psychotic disorders with or without comorbid substance use disorders: long-term outcome in evidence-based integrated care (ACCESS II study). Schizophr Res 222:437\u2013443","DOI":"10.1016\/j.schres.2020.03.058"},{"key":"4299_CR50","doi-asserted-by":"crossref","unstructured":"Karow A, Reimer J, K\u00f6nig HH et\u00a0al. (2012) Cost-effectiveness of 12-month therapeutic assertive community treatment in patients with schizophrenia spectrum disorders treated with quetiapine immediate release. J\u00a0Clin Psychiatry\u00a073:e204\u2013e210","DOI":"10.4088\/JCP.11m06875"},{"key":"4299_CR51","doi-asserted-by":"crossref","unstructured":"Karow A, Brettschneider C, Helmut K\u00f6nig H (2020) Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis. Acta Psychiatr Scand 141:221\u2013230","DOI":"10.1111\/acps.13139"},{"key":"4299_CR52","unstructured":"G\u00fchne U, Weinmann S, Arnold K, et\u00a0al. (2022) Stations\u00e4quivalente Behandlung (St\u00e4B) in Deutschland: Konzept, Implementierung und erste Evaluationsergebnisse. Nervenarzt\u00a093:117\u2013124"},{"key":"4299_CR53","unstructured":"Wullschleger A, Sch\u00f6ttle D, Karow A et\u00a0al. (2018) Sektoren\u00fcbergreifende Versorgung von Menschen mit schweren psychischen Erkrankungen: Evaluation von Modellvorhaben nach \u00a7\u00a064b\u00a0SGB\u00a0V. Psychiatr Prax\u00a045:284\u2013291"},{"key":"4299_CR54","unstructured":"DGPPN (2021) Positionspapier zur sektoren\u00fcbergreifenden Versorgung schwer psychisch erkrankter Menschen. Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde, Berlin"},{"key":"4299_CR55","doi-asserted-by":"publisher","unstructured":"Neumann A, Schmitt J, Seifert M et\u00a0al. (2024) Changes in patient care through flexible and integrated treatment programs in German psychiatric hospitals: meta-analyses based on a\u00a0series of controlled claims-based cohort studies. BMC Psychiatry\u00a024:74. https:\/\/doi.org\/10.1186\/s12888-024-05500-0","DOI":"10.1186\/s12888-024-05500-0"},{"key":"4299_CR56","doi-asserted-by":"crossref","unstructured":"Pfennig A, Soltmann B, Weinmann S et\u00a0al. (2025) Flexible, integrated, and person-centered psychiatric care through global treatment budgets: results of the multiperspective study PsychCare. Nervenarzt. 96(6):542\u2013550.","DOI":"10.1007\/s00115-025-01896-6"},{"key":"4299_CR57","doi-asserted-by":"crossref","unstructured":"Neumann A, Schmitt J, Seifert M et\u00a0al. (2026) Strengthening treatment options in the care of mentally ill patients through flexible and integrated treatment for patient-centered care with a\u00a0global budget: final results of the EVA64 study. Psychiatr Prax. 53(4):171\u2013181. German.","DOI":"10.1055\/a-2830-4639"},{"key":"4299_CR58","unstructured":"G\u00fchne U, Weinmann S, Becker T et\u00a0al. (2022) Koordinierte Versorgung bei schweren psychischen Erkrankungen: Chancen und Herausforderungen der KSVPsych-Richtlinie. Nervenarzt\u00a093:117\u2013124"},{"key":"4299_CR59","doi-asserted-by":"crossref","unstructured":"Loh PY, Martinengo L, Heaukulani C et\u00a0al. (2024) Characteristics and outcomes of mHealth interventions in psychosis: systematic mapping review. J\u00a0Med Internet Res\u00a026:e55924.","DOI":"10.2196\/55924"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-026-04299-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-026-04299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:45:53Z","timestamp":1790693153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-026-04299-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4299"],"URL":"https:\/\/doi.org\/10.1007\/s00103-026-04299-3","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Lambert ist Gesellschafter und Chief Medical Officer der MiNDNET E\u2011Health AG sowie der Mindnet E\u2011Health Solutions GmbH. Er erhielt Studienunterst\u00fctzungen von Janssen Cilag GmbH, MEDICE Arzneimittel P\u00fctter GmbH & Co. KG und Takeda Pharma GmbH. Beratungst\u00e4tigkeiten bestanden f\u00fcr Otsuka Pharma GmbH, TEVA GmbH und Takeda Pharma GmbH. Honorare f\u00fcr Vortr\u00e4ge wurden von Janssen Cilag GmbH, Otsuka Pharma GmbH, Boehringer Ingelheim International GmbH, ROVI GmbH und Takeda Pharma GmbH gezahlt. Ein Aktienbesitz besteht nicht. J.\u00a0Gallinat hat F\u00f6rdergelder f\u00fcr wissenschaftliche Studien von der Deutschen Forschungsgemeinschaft (DFG), dem Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt (BMFTR), dem Bundesministerium f\u00fcr Gesundheit (BMG) sowie Veranstaltungs- oder Vortragsunterst\u00fctzung von Lilly und Boehringer erhalten. A.\u00a0Zimmermann erhielt Honorar f\u00fcr Vortr\u00e4ge von Pfizer Pharma GmbH. Ein Aktienbesitz besteht nicht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen und Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}